News

Even though leprosy is not widespread in the United States, the current landscape in some cities, such as Los Angeles, is creating the perfect environment for so-called “ancient” diseases to flourish.

Study investigators assessed the nationwide incidence of sepsis within 42 days of delivery discharge.

Following outbreaks and disinfecting failures, new recommendations advocate for duodenoscopes with disposable components seek to drive change in reducing risk of patient infections.

A novel combination of ceftriaxone, sulbactam and disodium EDTA (CSE) was found noninferior to meropenem to treat cUTIs caused by gram-negative pathogens.

In this episode, we take a dual look at the recently announced changes to antibiotic reimbursements from the Centers for Medicare and Medicaid Services from both the clinician and industry perspective.

Japanese researchers work to refine RDV, a tool for rapid identification of pathogenic agents.

The team identified a new strain type within the emm1 bacteria group, which differed from the other emm1 strains by 27 genetic mutations.

Several cases of scombroid poisoning were reported on September 4, 2019, among individuals who consumed tuna steaks purchased from 3 different Kroger retail stores in Ohio.

There was no difference in HIV acquisition among women who used progestogen-only injectables, implants, or intrauterine devices.

An automatic, built-in alert shows promise in helping to de-escalate antibiotic use at a large community teaching hospital.

Investigators observed that, when compared with the general population of Guinea, survivors of Ebola had a 5-fold increased risk of mortality over a mean of 1 year of follow-up after discharge.

In 2018, the UK recorded 4484 new cases of HIV, representing a 28% decrease compared with the 6271 new diagnoses documented in 2015.

A new study using shotgun metagenomic sequencing found that FMT yielded a sustained decrease in antimicrobial resistance genes and potential pathogens in children with recurrent C diff.

A new article aims to help health care organizations set up antimicrobial stewardship programs based on sound scientific evidence.

Here is a look at infectious disease-related US Food and Drug Administration news from the week of September 1, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

That daily PrEP dose may not be necessary, according to a new study that examined time-driven and event-driven dosing in a high-risk population.

Researchers have hypothesized that the amount of time required to develop a novel antifungal therapeutic can be cut by repurposing drugs that are already FDA approved.

Cryptococcal meningitis is the leading cause of mortality in people living with HIV/AIDS, but a new study shows promising results for alternative treatments.

Natural disasters like hurricanes can have implications for public health, including a heightened risk of infectious diseases.

Bacteriocin operates effectively by damaging the cell walls of the target species, inducing cell perforation and blebbing, thus killing the cells.

Investigators have presented the microbiological, efficacy, and safety results in the pooled intravenous drug use vs non-intravenous drug use patients in 2 phase 3 ABSSSI studies, OASIS-1 and 2.

The in vitro activity of nano-mupirocin, as well as its distribution to vaginal mucus, strongly support its development for the treatment of MDR gonorrhea.

A new study sheds light on the relationship between fungi and C diff infections.

Being geographically close a measles outbreak could change the way individuals feel about getting vaccinated against the disease.

Adding post market adaptive studies to existing noninferiority trials can provide clinicians with necessary data without slowing market introduction.

The MINISTONE-2 study enrolled pediatric patients and the BLOCKSTONE study looked at preventive treatment for individuals living with someone with an influenza infection.